Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPH Trial
NCT02975323Phase 3Unknown
- Sponsor
- Aga Khan University
- Start
- Dec 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of carvedilol in Portal Hypertension (PH), sponsored by Aga Khan University. Primary endpoint: Assessment of Correlation of HWF as detected on doppler ultrasound and HVPG as assessed at hepatic vein catherization at 6 hours. Status: unknown.
02
Drugs
carvedilol
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT02975323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975323.